{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:36:46Z","timestamp":1779896206777,"version":"3.53.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,1,4]],"date-time":"2015-01-04T00:00:00Z","timestamp":1420329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s11102-014-0630-5","type":"journal-article","created":{"date-parts":[[2015,1,3]],"date-time":"2015-01-03T02:35:11Z","timestamp":1420252511000},"page":"674-684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells"],"prefix":"10.1007","volume":"18","author":[{"given":"Mark O.","family":"Kitchen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiren","family":"Yacqub-Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Emes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard N.","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,4]]},"reference":[{"issue":"11","key":"630_CR1","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI20401","volume":"112","author":"S Melmed","year":"2003","unstructured":"Melmed S (2003) Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest 112(11):1603\u20131618. doi: 10.1172\/jci20401","journal-title":"J Clin Invest"},{"issue":"5","key":"630_CR2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrendo.2011.40","volume":"7","author":"S Melmed","year":"2011","unstructured":"Melmed S (2011) Pathogenesis of pituitary tumors. Nat Rev Endocrinol 7(5):257\u2013266. doi: 10.1038\/nrendo.2011.40","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"630_CR3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1677\/JME-09-0009","volume":"42","author":"KJ Dudley","year":"2009","unstructured":"Dudley KJ, Revill K, Clayton RN, Farrell WE (2009) Pituitary tumours: all silent on the epigenetics front. J Mol Endocrinol 42(6):461\u2013468. doi: 10.1677\/jme-09-0009","journal-title":"J Mol Endocrinol"},{"issue":"3","key":"630_CR4","first-page":"461","volume":"24","author":"S Vandeva","year":"2010","unstructured":"Vandeva S, Jaffrain-Rea ML, Daly AF, Tichomirowa M, Zacharieva S, Beckers A (2010) The genetics of pituitary adenomas. Best practice & research. Clin Endocrinol Metab 24(3):461\u2013476. doi: 10.1016\/j.beem.2010.03.001","journal-title":"Clin Endocrinol Metab"},{"key":"630_CR5","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, Zhang X, Klibanski A (2013) Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma. Mol Cell Endocrinol. doi: 10.1016\/j.mce.2013.09.006","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"630_CR6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1530\/ERC-12-0251","volume":"19","author":"CV Duong","year":"2012","unstructured":"Duong CV, Emes RD, Wessely F, Yacqub-Usman K, Clayton RN, Farrell WE (2012) Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas. Endocr Relat Cancer 19(6):805\u2013816. doi: 10.1530\/ERC-12-0251","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"630_CR7","doi-asserted-by":"crossref","first-page":"e82619","DOI":"10.1371\/journal.pone.0082619","volume":"8","author":"M Pease","year":"2013","unstructured":"Pease M, Ling C, Mack WJ, Wang K, Zada G (2013) The role of epigenetic modification in tumorigenesis and progression of pituitary adenomas: a systematic review of the literature. PLoS One 8(12):e82619. doi: 10.1371\/journal.pone.0082619","journal-title":"PLoS One"},{"issue":"6","key":"630_CR8","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1172\/JCI11887","volume":"107","author":"BE Hayward","year":"2001","unstructured":"Hayward BE, Barlier A, Korbonits M, Grossman AB, Jacquet P, Enjalbert A, Bonthron DT (2001) Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 107(6):R31\u2013R36. doi: 10.1172\/jci11887","journal-title":"J Clin Invest"},{"issue":"18","key":"630_CR9","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.4161\/cc.5.18.3211","volume":"5","author":"M Fedele","year":"2006","unstructured":"Fedele M, Pierantoni GM, Visone R, Fusco A (2006) Critical role of the HMGA2 gene in pituitary adenomas. Cell Cycle 5(18):2045\u20132048","journal-title":"Cell Cycle"},{"issue":"8","key":"630_CR10","first-page":"2398","volume":"62","author":"P Finelli","year":"2002","unstructured":"Finelli P, Pierantoni GM, Giardino D, Losa M, Rodeschini O, Fedele M, Valtorta E, Mortini P, Croce CM, Larizza L, Fusco A (2002) The high mobility group A2 gene is amplified and overexpressed in human prolactinomas. Cancer Res 62(8):2398\u20132405","journal-title":"Cancer Res"},{"issue":"34","key":"630_CR11","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1038\/onc.2011.557","volume":"31","author":"D Palmieri","year":"2012","unstructured":"Palmieri D, D\u2019Angelo D, Valentino T, De Martino I, Ferraro A, Wierinckx A, Fedele M, Trouillas J, Fusco A (2012) Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis. Oncogene 31(34):3857\u20133865. doi: 10.1038\/onc.2011.557","journal-title":"Oncogene"},{"issue":"5740","key":"630_CR12","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1111444","volume":"309","author":"PD Zamore","year":"2005","unstructured":"Zamore PD, Haley B (2005) Ribo-gnome: the big world of small RNAs. Science 309(5740):1519\u20131524. doi: 10.1126\/science.1111444","journal-title":"Science"},{"issue":"2","key":"630_CR13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrg2936","volume":"12","author":"E Huntzinger","year":"2011","unstructured":"Huntzinger E, Izaurralde E (2011) Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12(2):99\u2013110. doi: 10.1038\/nrg2936","journal-title":"Nat Rev Genet"},{"issue":"7","key":"630_CR14","doi-asserted-by":"crossref","first-page":"E1128","DOI":"10.1210\/jc.2011-3482","volume":"97","author":"D D\u2019Angelo","year":"2012","unstructured":"D\u2019Angelo D, Palmieri D, Mussnich P, Roche M, Wierinckx A, Raverot G, Fedele M, Croce CM, Trouillas J, Fusco A (2012) Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1. J Clin Endocrinol Metab 97(7):E1128\u2013E1138. doi: 10.1210\/jc.2011-3482","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"630_CR15","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/onc.2012.190","volume":"32","author":"T Palumbo","year":"2013","unstructured":"Palumbo T, Faucz FR, Azevedo M, Xekouki P, Iliopoulos D, Stratakis CA (2013) Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN\u2013AKT pathway. Oncogene 32(13):1651\u20131659. doi: 10.1038\/onc.2012.190","journal-title":"Oncogene"},{"issue":"5","key":"630_CR16","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1210\/en.2012-2070","volume":"154","author":"E Gentilin","year":"2013","unstructured":"Gentilin E, Tagliati F, Filieri C, Mole D, Minoia M, Rosaria Ambrosio M, Degli Uberti EC, Zatelli MC (2013) miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase Cdelta. Endocrinology 154(5):1690\u20131700. doi: 10.1210\/en.2012-2070","journal-title":"Endocrinology"},{"key":"630_CR17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/B978-0-12-380866-0.60004-6","volume":"70","author":"M Fabbri","year":"2010","unstructured":"Fabbri M, Calin GA (2010) Epigenetics and miRNAs in human cancer. Adv Genet 70:87\u201399. doi: 10.1016\/B978-0-12-380866-0.60004-6","journal-title":"Adv Genet"},{"issue":"6","key":"630_CR18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccr.2006.04.020","volume":"9","author":"Y Saito","year":"2006","unstructured":"Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9(6):435\u2013443. doi: 10.1016\/j.ccr.2006.04.020","journal-title":"Cancer Cell"},{"issue":"2","key":"630_CR19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/en.2010-0886","volume":"152","author":"H Al-Azzawi","year":"2011","unstructured":"Al-Azzawi H, Yacqub-Usman K, Richardson A, Hofland LJ, Clayton RN, Farrell WE (2011) Reversal of endogenous dopamine receptor silencing in pituitary cells augments receptor-mediated apoptosis. Endocrinology 152(2):364\u2013373. doi: 10.1210\/en.2010-0886","journal-title":"Endocrinology"},{"key":"630_CR20","author":"K Yacqub-Usman","year":"2012","unstructured":"Yacqub-Usman K, Duong CV, Clayton RN, Farrell WE (2012) Epigenomic silencing of the BMP-4 gene in pituitary adenomas: a potential target for epidrug-induced re-expression. Endocrinology. doi: 10.1210\/en.2012-1231","journal-title":"Endocrinology"},{"key":"630_CR21","doi-asserted-by":"crossref","first-page":"D154","DOI":"10.1093\/nar\/gkm952","volume":"36","author":"S Griffiths-Jones","year":"2008","unstructured":"Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36:D154\u2013D158. doi: 10.1093\/nar\/gkm952","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"630_CR22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.gpb.2012.08.005","volume":"10","author":"M Bhattacharyya","year":"2012","unstructured":"Bhattacharyya M, Das M, Bandyopadhyay S (2012) miRT: a database of validated transcription start sites of human microRNAs. Genomics Proteomics Bioinformatics 10(5):310\u2013316. doi: 10.1016\/j.gpb.2012.08.005","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"21","key":"630_CR23","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1093\/nar\/gkr604","volume":"39","author":"CH Chien","year":"2011","unstructured":"Chien CH, Sun YM, Chang WC, Chiang-Hsieh PY, Lee TY, Tsai WC, Horng JT, Tsou AP, Huang HD (2011) Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data. Nucleic Acids Res 39(21):9345\u20139356. doi: 10.1093\/nar\/gkr604","journal-title":"Nucleic Acids Res"},{"key":"630_CR24","doi-asserted-by":"crossref","unstructured":"Kramer MF (2011) Stem-loop RT-qPCR for miRNAs. In: Frederick M. Ausubel et al. (ed) Current protocols in molecular biology 15(15\u201310). doi: 10.1002\/0471142727.mb1510s95","DOI":"10.1002\/0471142727.mb1510s95"},{"issue":"20","key":"630_CR25","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1093\/nar\/gni178","volume":"33","author":"C Chen","year":"2005","unstructured":"Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33(20):e179. doi: 10.1093\/nar\/gni178","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"630_CR26","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1210\/me.2004-0087","volume":"18","author":"A Bahar","year":"2004","unstructured":"Bahar A, Simpson DJ, Cutty SJ, Bicknell JE, Hoban PR, Holley S, Mourtada-Maarabouni M, Williams GT, Clayton RN, Farrell WE (2004) Isolation and characterization of a novel pituitary tumor apoptosis gene. Mol Endocrinol 18(7):1827\u20131839. doi: 10.1210\/me.2004-0087","journal-title":"Mol Endocrinol"},{"issue":"5","key":"630_CR27","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1261\/rna.939908","volume":"14","author":"HJ Peltier","year":"2008","unstructured":"Peltier HJ, Latham GJ (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14(5):844\u2013852. doi: 10.1261\/rna.939908","journal-title":"RNA"},{"issue":"2","key":"630_CR28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1677\/ERC-09-0008","volume":"16","author":"K Revill","year":"2009","unstructured":"Revill K, Dudley KJ, Clayton RN, McNicol AM, Farrell WE (2009) Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma. Endocr Relat Cancer 16(2):537\u2013548. doi: 10.1677\/ERC-09-0008","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"630_CR29","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1158\/1541-7786.MCR-08-0234","volume":"6","author":"KJ Dudley","year":"2008","unstructured":"Dudley KJ, Revill K, Whitby P, Clayton RN, Farrell WE (2008) Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors. MCR 6(10):1567\u20131574. doi: 10.1158\/1541-7786.mcr-08-0234","journal-title":"MCR"},{"issue":"5532","key":"630_CR30","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","volume":"293","author":"T Jenuwein","year":"2001","unstructured":"Jenuwein T, Allis CD (2001) Translating the histone code. Science (New York, N.Y.) 293(5532):1074\u20131080. doi: 10.1126\/science.1063127","journal-title":"Science (New York, N.Y.)"},{"issue":"5595","key":"630_CR31","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","volume":"298","author":"R Cao","year":"2002","unstructured":"Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science (New York, N.Y.) 298(5595):1039\u20131043. doi: 10.1126\/science.1076997","journal-title":"Science (New York, N.Y.)"},{"key":"630_CR32","first-page":"5","volume":"32","author":"JM Walker","year":"1994","unstructured":"Walker JM (1994) The bicinchoninic acid (BCA) assay for protein quantitation. Methods Mol Biol 32:5\u20138. doi: 10.1385\/0-89603-268-x:5","journal-title":"Methods Mol Biol"},{"issue":"4","key":"630_CR33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1677\/erc.1.01049","volume":"12","author":"GM Pierantoni","year":"2005","unstructured":"Pierantoni GM, Finelli P, Valtorta E, Giardino D, Rodeschini O, Esposito F, Losa M, Fusco A, Larizza L (2005) High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy. Endocr Relat Cancer 12(4):867\u2013874. doi: 10.1677\/erc.1.01049","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"630_CR34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12022-009-9094-y","volume":"20","author":"EL Wang","year":"2009","unstructured":"Wang EL, Qian ZR, Yamada S, Rahman MM, Inosita N, Kageji T, Endo H, Kudo E, Sano T (2009) Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomas. Endocr Pathol 20(4):209\u2013220. doi: 10.1007\/s12022-009-9094-y","journal-title":"Endocr Pathol"},{"issue":"11","key":"630_CR35","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/onc.2008.495","volume":"28","author":"I Martino De","year":"2009","unstructured":"De Martino I, Visone R, Fedele M, Petrocca F, Palmieri D, Martinez Hoyos J, Forzati F, Croce CM, Fusco A (2009) Regulation of microRNA expression by HMGA1 proteins. Oncogene 28(11):1432\u20131442. doi: 10.1038\/onc.2008.495","journal-title":"Oncogene"},{"issue":"14","key":"630_CR36","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1073\/pnas.141224998","volume":"98","author":"G Baldassarre","year":"2001","unstructured":"Baldassarre G, Fedele M, Battista S, Vecchione A, Klein-Szanto AJ, Santoro M, Waldmann TA, Azimi N, Croce CM, Fusco A (2001) Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc Natl Acad Sci USA 98(14):7970\u20137975. doi: 10.1073\/pnas.141224998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"630_CR37","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1038\/sj.onc.1205428","volume":"21","author":"M Fedele","year":"2002","unstructured":"Fedele M, Battista S, Kenyon L, Baldassarre G, Fidanza V, Klein-Szanto AJ, Parlow AF, Visone R, Pierantoni GM, Outwater E, Santoro M, Croce CM, Fusco A (2002) Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene 21(20):3190\u20133198. doi: 10.1038\/sj.onc.1205428","journal-title":"Oncogene"},{"issue":"21","key":"630_CR38","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1038\/sj.onc.1208501","volume":"24","author":"M Fedele","year":"2005","unstructured":"Fedele M, Pentimalli F, Baldassarre G, Battista S, Klein-Szanto AJ, Kenyon L, Visone R, De Martino I, Ciarmiello A, Arra C, Viglietto G, Croce CM, Fusco A (2005) Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone\/prolactin cell pituitary adenomas and natural killer cell lymphomas. Oncogene 24(21):3427\u20133435. doi: 10.1038\/sj.onc.1208501","journal-title":"Oncogene"},{"issue":"1\u20132","key":"630_CR39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mce.2010.03.019","volume":"326","author":"M Fedele","year":"2010","unstructured":"Fedele M, Palmieri D, Fusco A (2010) HMGA2: A pituitary tumour subtype-specific oncogene? Mol Cell Endocrinol 326(1\u20132):19\u201324. doi: 10.1016\/j.mce.2010.03.019","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"630_CR40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11102-010-0268-x","volume":"14","author":"H Butz","year":"2011","unstructured":"Butz H, Liko I, Czirjak S, Igaz P, Korbonits M, Racz K, Patocs A (2011) MicroRNA profile indicates downregulation of the TGFbeta pathway in sporadic non-functioning pituitary adenomas. Pituitary 14(2):112\u2013124. doi: 10.1007\/s11102-010-0268-x","journal-title":"Pituitary"},{"issue":"5","key":"630_CR41","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1210\/en.2013-1061","volume":"154","author":"K Yacqub-Usman","year":"2013","unstructured":"Yacqub-Usman K, Duong CV, Clayton RN, Farrell WE (2013) Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin A are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes. Endocrinology 154(5):1711\u20131721. doi: 10.1210\/en.2013-1061","journal-title":"Endocrinology"},{"issue":"4","key":"630_CR42","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1158\/0008-5472.CAN-06-4218","volume":"67","author":"A Lujambio","year":"2007","unstructured":"Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setien F, Casado S, Suarez-Gauthier A, Sanchez-Cespedes M, Git A, Spiteri I, Das PP, Caldas C, Miska E, Esteller M (2007) Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67(4):1424\u20131429. doi: 10.1158\/0008-5472.CAN-06-4218","journal-title":"Cancer Res"},{"issue":"1","key":"630_CR43","first-page":"10","volume":"27","author":"LV Rhodes","year":"2012","unstructured":"Rhodes LV, Nitschke AM, Segar HC, Martin EC, Driver JL, Elliott S, Nam SY, Li M, Nephew KP, Burow ME, Collins-Burow BM (2012) The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells. Oncol Rep 27(1):10\u201316. doi: 10.3892\/or.2011.1488","journal-title":"Oncol Rep"},{"issue":"5","key":"630_CR44","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood-2011-05-351510","volume":"119","author":"D Sampath","year":"2012","unstructured":"Sampath D, Liu C, Vasan K, Sulda M, Puduvalli VK, Wierda WG, Keating MJ (2012) Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia. Blood 119(5):1162\u20131172. doi: 10.1182\/blood-2011-05-351510","journal-title":"Blood"},{"issue":"1\u20132","key":"630_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2014.03.002","volume":"390","author":"V Leone","year":"2014","unstructured":"Leone V, Langella C, D\u2019Angelo D, Mussnich P, Wierinckx A, Terracciano L, Raverot G, Lachuer J, Rotondi S, Jaffrain-Rea ML, Trouillas J, Fusco A (2014) miR-23b and miR-130b expression is downregulated in pituitary adenomas. Mol Cell Endocrinol 390(1\u20132):1\u20137. doi: 10.1016\/j.mce.2014.03.002","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"630_CR46","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/jcp.20832","volume":"210","author":"A Bottoni","year":"2007","unstructured":"Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C, Calin GA, Negrini M, Croce CM, Degli Uberti EC (2007) Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol 210(2):370\u2013377. doi: 10.1002\/jcp.20832","journal-title":"J Cell Physiol"},{"key":"630_CR47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1746-1596-5-79","volume":"5","author":"ZG Mao","year":"2010","unstructured":"Mao ZG, He DS, Zhou J, Yao B, Xiao WW, Chen CH, Zhu YH, Wang HJ (2010) Differential expression of microRNAs in GH-secreting pituitary adenomas. Diagn Pathol 5:79. doi: 10.1186\/1746-1596-5-79","journal-title":"Diagn Pathol"},{"issue":"10","key":"630_CR48","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/BF03346759","volume":"36","author":"MR Gadelha","year":"2013","unstructured":"Gadelha MR, Kasuki L, Denes J, Trivellin G, Korbonits M (2013) MicroRNAs: suggested role in pituitary adenoma pathogenesis. J Endocrinol Invest 36(10):889\u2013895","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"630_CR49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3803\/EnM.2013.28.4.245","volume":"28","author":"X Jiang","year":"2013","unstructured":"Jiang X, Zhang X (2013) The molecular pathogenesis of pituitary adenomas: an update. Endocrinol Metab 28(4):245\u2013254. doi: 10.3803\/EnM.2013.28.4.245","journal-title":"Endocrinol Metab"},{"issue":"3","key":"630_CR50","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.mehy.2011.12.001","volume":"78","author":"X Shi","year":"2012","unstructured":"Shi X, Tao B, He H, Sun Q, Fan C, Bian L, Zhao W, Lu YC (2012) MicroRNAs-based network: a novel therapeutic agent in pituitary adenoma. Med Hypotheses 78(3):380\u2013384. doi: 10.1016\/j.mehy.2011.12.001","journal-title":"Med Hypotheses"},{"issue":"4","key":"630_CR51","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MED.0b013e328354b2e2","volume":"19","author":"S Rostad","year":"2012","unstructured":"Rostad S (2012) Pituitary adenoma pathogenesis: an update. Curr Opin Endocrinol Diabetes Obes 19(4):322\u2013327. doi: 10.1097\/MED.0b013e328354b2e2","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"8","key":"630_CR52","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nrendo.2012.54","volume":"8","author":"K Yacqub-Usman","year":"2012","unstructured":"Yacqub-Usman K, Richardson A, Duong CV, Clayton RN, Farrell WE (2012) The pituitary tumour epigenome: aberrations and prospects for targeted therapy. Nat Rev Endocrinol 8(8):486\u2013494. doi: 10.1038\/nrendo.2012.54","journal-title":"Nat Rev Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-014-0630-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-014-0630-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-014-0630-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T02:08:23Z","timestamp":1559354903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-014-0630-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,4]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["630"],"URL":"https:\/\/doi.org\/10.1007\/s11102-014-0630-5","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,4]]}}}